Stallion India Fluorochemicals Approves Allotment of 3.67 Cr Equity Shares via Rights Issue
Stallion India Fluorochemicals approved the allotment of 3,67,60,483 equity shares via rights issue. The shares were issued at ₹99 each, including a ₹89 premium. The Board's Right Issue Committee approved this on March 02, 2026. Newspaper publication was on March 06, 2026.
The rights issue involves a significant number of shares and a substantial issue price, indicating a material capital raising event for the company.
The company successfully completed a rights issue, which is generally a positive sign of capital infusion and shareholder confidence.
Stallion India Fluorochemicals Limited has announced the approval of the allotment of 3,67,60,483 fully paid-up equity shares. These shares, with a face value of ₹10.00 each, were issued on a rights basis to eligible shareholders and/or renouncees at an issue price of ₹99 per equity share, which includes a premium of ₹89 per share. The decision was made by the Right Issue Committee of the Board of Directors during their meeting held on Monday, March 02, 2026. This development is in compliance with SEBI regulations, and extracts of the newspaper publication, dated March 06th, 2026, have been submitted to the National Stock Exchange (NSE) and BSE Limited.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.